Germany
Japan
United Kingdom
China
Lenti ORF particles, IL1RAP (Myc-DDK tagged) - Human interleukin 1 receptor accessory protein (IL1RAP), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lentiviral Particles
Lenti ORF particles, MSH3 (Myc-DDK tagged) - Human mutS homolog 3 (E. coli) (MSH3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, HYAL2 (Myc-DDK tagged) - Human hyaluronoglucosaminidase 2 (HYAL2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, ROR2 (Myc-DDK tagged) - Human receptor tyrosine kinase-like orphan receptor 2 (ROR2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, MGLL (Myc-DDK tagged) - Human monoglyceride lipase (MGLL), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, SMPD1 (Myc-DDK tagged) - Human sphingomyelin phosphodiesterase 1, acid lysosomal (SMPD1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MFRP (Myc-DDK tagged) - Human membrane frizzled-related protein (MFRP), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CTNND1 (Myc-DDK tagged) - Human catenin (cadherin-associated protein), delta 1 (CTNND1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, ROBO2 (Myc-DDK tagged) - Human roundabout, axon guidance receptor, homolog 2 (Drosophila) (ROBO2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PYGB (Myc-DDK tagged) - Human phosphorylase, glycogen; brain (PYGB), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,584.00
2 Weeks
Lenti ORF particles, CASR (Myc-DDK tagged) - Human calcium-sensing receptor (CASR), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, LOXL2 (Myc-DDK tagged) - Human lysyl oxidase-like 2 (LOXL2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, IGFBP2 (Myc-DDK tagged) - Human insulin-like growth factor binding protein 2, 36kDa (IGFBP2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, FGFR4 (Myc-DDK tagged) - Human fibroblast growth factor receptor 4 (FGFR4), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, SDC4 (Myc-DDK tagged) - Human syndecan 4 (SDC4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, AGER (Myc-DDK tagged) - Human advanced glycosylation end product-specific receptor (AGER), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TIE1 (Myc-DDK tagged) - Human tyrosine kinase with immunoglobulin-like and EGF-like domains 1 (TIE1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, LILRB3 (Myc-DDK tagged) - Human leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 (LILRB3), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,428.00
3 Weeks
Lenti ORF particles, BCL11B (Myc-DDK tagged) - Human B-cell CLL/lymphoma 11B (zinc finger protein) (BCL11B), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, LTB4R2 (Myc-DDK tagged) - Human leukotriene B4 receptor 2 (LTB4R2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, FUT2 (Myc-DDK tagged) - Human fucosyltransferase 2 (secretor status included) (FUT2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, RTEL1 (Myc-DDK tagged) - Human regulator of telomere elongation helicase 1 (RTEL1), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,296.00
5 Weeks
Lenti ORF particles, KIF2C (Myc-DDK tagged) - Human kinesin family member 2C (KIF2C), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, STUB1 (Myc-DDK tagged) - Human STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase (STUB1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, NRAS (Myc-DDK tagged) - Human neuroblastoma RAS viral (v-ras) oncogene homolog (NRAS), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, FTL (Myc-DDK tagged) - Human ferritin, light polypeptide (FTL), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, PELI2 (Myc-DDK tagged) - Human pellino homolog 2 (Drosophila) (PELI2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,248.00
5 Weeks
Lenti ORF particles, CDH11 (Myc-DDK tagged) - Human cadherin 11, type 2, OB-cadherin (osteoblast) (CDH11), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TNFRSF1A (Myc-DDK tagged) - Human tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PERP (Myc-DDK tagged) - Human PERP, TP53 apoptosis effector (PERP), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, RTN4R (Myc-DDK tagged) - Human reticulon 4 receptor (RTN4R), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, RRAS2 (Myc-DDK tagged) - Human related RAS viral (r-ras) oncogene homolog 2 (RRAS2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, CDKN2B (Myc-DDK tagged) - Human cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, SSTR2 (Myc-DDK tagged) - Human somatostatin receptor 2 (SSTR2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, RASA1 (Myc-DDK tagged) - Human RAS p21 protein activator (GTPase activating protein) 1 (RASA1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CBLB (Myc-DDK tagged) - Human Cas-Br-M (murine) ecotropic retroviral transforming sequence b (CBLB), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, TNFAIP6 (Myc-DDK tagged) - Human tumor necrosis factor, alpha-induced protein 6 (TNFAIP6), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, PDGFB (Myc-DDK tagged) - Human platelet-derived growth factor beta polypeptide (PDGFB), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, BST2 (Myc-DDK tagged) - Human bone marrow stromal cell antigen 2 (BST2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,152.00
6 Weeks
Lenti ORF particles, MTL5 (Myc-DDK-tagged)-Human metallothionein-like 5, testis-specific (tesmin) (MTL5), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 2,244.00
3 Weeks
Lenti ORF particles, GPR116 (Myc-DDK-tagged)-Human G protein-coupled receptor 116 (GPR116), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TRIB1 (Myc-DDK tagged) - Human tribbles homolog 1 (Drosophila) (TRIB1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, IFNG (Myc-DDK tagged) - Human interferon, gamma (IFNG), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, GPRC5D (Myc-DDK tagged) - Human G protein-coupled receptor, family C, group 5, member D (GPRC5D), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, CNR2 (Myc-DDK tagged) - Human cannabinoid receptor 2 (macrophage) (CNR2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SLC7A3 (Myc-DDK tagged) - Human solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 (SLC7A3), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,920.00
6 Weeks
Lenti ORF particles, FBXO18 (Myc-DDK tagged) - Human F-box protein, helicase, 18 (FBXO18), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, BACH2 (Myc-DDK tagged) - Human BTB and CNC homology 1, basic leucine zipper transcription factor 2 (BACH2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, PPARA (Myc-DDK tagged) - Human peroxisome proliferator-activated receptor alpha (PPARA), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, FKBP8 (Myc-DDK tagged) - Human FK506 binding protein 8, 38kDa (FKBP8), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Active filters
Vectors
- pLenti-C-Myc-DDK-P2A-Puro
Families
- Druggable Genome
Filter by
Target Symbol
- PDE9A (20)
- NRG1 (18)
- CREM (17)
- DTNA (17)
- BDNF (16)
- VEGFA (16)
- NR1I3 (15)
- CD1E (13)
- CTNND1 (13)
- DAG1 (13)
- OPRM1 (13)
- ASPH (12)
- ATXN3 (12)
- CD46 (12)
- FGFR1 (11)
- SERPINA1 (11)
- MADD (10)
- PTPN20 (10)
- TCF7L2 (10)
- ABL2 (9)
- ADGRG2 (9)
- APTX (9)
- BCAR1 (9)
- CACNB2 (9)
- CSF2RA (9)
- FGFR2 (9)
- HFE (9)
- NEDD4L (9)
- NF2 (9)
- PDE4D (9)
- PML (9)
- PTGER3 (9)
- PTPN20A (9)
- ADGRG1 (8)
- CAMK2B (8)
- CD59 (8)
- CHRM2 (8)
- ENSA (8)
- GSN (8)
- IP6K2 (8)
- MID1 (8)
- MITF (8)
- MYB (8)
- OGG1 (8)
- PAX3 (8)
- PCSK6 (8)
- RAD17 (8)
- TGIF1 (8)
- TNIK (8)
- TRPM3 (8)
- ANAPC11 (7)
- APP (7)
- ATP2A3 (7)
- CAMKK2 (7)
- CAPN3 (7)
- CHAT (7)
- CPT1B (7)
- DBI (7)
- GABRA1 (7)
- HMGA1 (7)
- IMPDH1 (7)
- KCNIP2 (7)
- MAP7 (7)
- MEN1 (7)
- MUC1 (7)
- NEK6 (7)
- NR3C1 (7)
- PPP2R2B (7)
- PREPL (7)
- PROM1 (7)
- PTCH1 (7)
- RABL2B (7)
- RASGRP4 (7)
- SEPT9 (7)
- SIGLEC10 (7)
- SMARCA4 (7)
- SORBS1 (7)
- TP53 (7)
- TPM1 (7)
- ABCG1 (6)
- ADAM15 (6)
- AFF2 (6)
- AGL (6)
- AMZ2 (6)
- ASNS (6)
- AURKA (6)
- BTNL8 (6)
- CAMK2D (6)
- CARD8 (6)
- CASP8 (6)
- CDK11B (6)
- CLEC7A (6)
- CNBP (6)
- CNOT4 (6)
- DCN (6)
- DCTN1 (6)
- EPB41 (6)
- FGF1 (6)
- GIT2 (6)
- GUCY1A1 (6)
Species
Lentivirus
Tags
Mutants
Mammalian Cell Selection
Pathways
- Metabolic pathways (892)
- Pathways in cancer (571)
- MAPK signaling pathway (444)
- Neuroactive ligand-receptor interaction (440)
- Cytokine-cytokine receptor interaction (427)
- Regulation of actin cytoskeleton (308)
- Focal adhesion (289)
- Chemokine signaling pathway (282)
- Calcium signaling pathway (281)
- Wnt signaling pathway (239)
- Neurotrophin signaling pathway (237)
- Jak-STAT signaling pathway (230)
- Progesterone-mediated oocyte maturation (211)
- Insulin signaling pathway (196)
- Purine metabolism (195)
- T cell receptor signaling pathway (195)
- Endocytosis (190)
- Cell cycle (187)
- ErbB signaling pathway (186)
- Natural killer cell mediated cytotoxicity (186)
- Axon guidance (178)
- Apoptosis (173)
- Oocyte meiosis (170)
- Prostate cancer (170)
- Toll-like receptor signaling pathway (169)
- Hematopoietic cell lineage (165)
- Adherens junction (163)
- Ubiquitin mediated proteolysis (160)
- Colorectal cancer (158)
- Alzheimer's disease (157)
- Leukocyte transendothelial migration (157)
- GnRH signaling pathway (156)
- Pancreatic cancer (151)
- Melanogenesis (150)
- Vascular smooth muscle contraction (144)
- Cell adhesion molecules (CAMs) (143)
- Gap junction (136)
- VEGF signaling pathway (136)
- Huntington's disease (135)
- Dilated cardiomyopathy (134)
- Olfactory transduction (134)
- B cell receptor signaling pathway (131)
- Chronic myeloid leukemia (131)
- Renal cell carcinoma (131)
- Melanoma (130)
- Tight junction (129)
- Small cell lung cancer (128)
- TGF-beta signaling pathway (128)
- p53 signaling pathway (128)
- Fc gamma R-mediated phagocytosis (125)
- Hypertrophic cardiomyopathy (HCM) (125)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (122)
- Fc epsilon RI signaling pathway (118)
- Glioma (118)
- Lysosome (118)
- NOD-like receptor signaling pathway (117)
- Acute myeloid leukemia (116)
- Adipocytokine signaling pathway (114)
- Complement and coagulation cascades (114)
- Long-term potentiation (111)
- Phosphatidylinositol signaling system (108)
- Long-term depression (107)
- Endometrial cancer (105)
- Amyotrophic lateral sclerosis (ALS) (100)
- RIG-I-like receptor signaling pathway (98)
- PPAR signaling pathway (97)
- Non-small cell lung cancer (95)
- ECM-receptor interaction (94)
- Bladder cancer (92)
- Basal cell carcinoma (81)
- Glycolysis / Gluconeogenesis (81)
- Epithelial cell signaling in Helicobacter pylori infection (79)
- Inositol phosphate metabolism (77)
- Viral myocarditis (76)
- mTOR signaling pathway (73)
- Type II diabetes mellitus (72)
- Drug metabolism - cytochrome P450 (69)
- Thyroid cancer (68)
- Cardiac muscle contraction (66)
- Hedgehog signaling pathway (66)
- Pathogenic Escherichia coli infection (66)
- Metabolism of xenobiotics by cytochrome P450 (65)
- Pyrimidine metabolism (65)
- Glycerophospholipid metabolism (64)
- ABC transporters (62)
- Valine (62)
- Cytosolic DNA-sensing pathway (61)
- Antigen processing and presentation (60)
- Arachidonic acid metabolism (60)
- Parkinson's disease (59)
- Retinol metabolism (59)
- Arginine and proline metabolism (57)
- Primary immunodeficiency (56)
- Glycerolipid metabolism (54)
- Base excision repair (53)
- Drug metabolism - other enzymes (53)
- Tyrosine metabolism (53)
- leucine and isoleucine degradation (49)
- Fatty acid metabolism (46)
- Glutathione metabolism (46)
- Autoimmune thyroid disease (45)
- Lysine degradation (45)
- Sphingolipid metabolism (45)
- Systemic lupus erythematosus (45)
- Taste transduction (44)
- Fructose and mannose metabolism (43)
- Cysteine and methionine metabolism (42)
- Prion diseases (42)
- Nucleotide excision repair (41)
- SNARE interactions in vesicular transport (40)
- Starch and sucrose metabolism (40)
- Vibrio cholerae infection (40)
- Amino sugar and nucleotide sugar metabolism (39)
- Galactose metabolism (39)
- Pyruvate metabolism (38)
- Tryptophan metabolism (38)
- Butanoate metabolism (36)
- Type I diabetes mellitus (35)
- Alanine (34)
- Notch signaling pathway (34)
- aspartate and glutamate metabolism (34)
- Proteasome (33)
- Homologous recombination (32)
- Linoleic acid metabolism (32)
- Histidine metabolism (31)
- Pentose phosphate pathway (31)
- Aminoacyl-tRNA biosynthesis (30)
- Androgen and estrogen metabolism (30)
- Ether lipid metabolism (30)
- Nitrogen metabolism (30)
- Oxidative phosphorylation (30)
- Maturity onset diabetes of the young (29)
- Propanoate metabolism (29)
- Renin-angiotensin system (29)
- Citrate cycle (TCA cycle) (27)
- Regulation of autophagy (27)
- Allograft rejection (26)
- Mismatch repair (26)
- Glycosaminoglycan degradation (23)
- Porphyrin and chlorophyll metabolism (23)
- Riboflavin metabolism (23)
- Phenylalanine metabolism (22)
- Spliceosome (22)
- Dorso-ventral axis formation (21)
- Pantothenate and CoA biosynthesis (21)
- Ribosome (21)
- Selenoamino acid metabolism (21)
- Non-homologous end-joining (20)
- beta-Alanine metabolism (20)
- leucine and isoleucine biosynthesis (20)
- Graft-versus-host disease (19)
- DNA replication (18)
- Glycine (18)
- N-Glycan biosynthesis (18)
- Other glycan degradation (18)
- Steroid biosynthesis (18)
- serine and threonine metabolism (18)
- C21-Steroid hormone metabolism (17)
- Circadian rhythm - mammal (16)
- Primary bile acid biosynthesis (16)
- alpha-Linolenic acid metabolism (16)
- Asthma (15)
- Folate biosynthesis (14)
- Terpenoid backbone biosynthesis (14)
- Synthesis and degradation of ketone bodies (12)
- Basal transcription factors (11)
- RNA degradation (11)
- Nicotinate and nicotinamide metabolism (10)
- Pentose and glucuronate interconversions (10)
- Ascorbate and aldarate metabolism (9)
- Glyoxylate and dicarboxylate metabolism (9)
- Biosynthesis of unsaturated fatty acids (8)
- Glycosphingolipid biosynthesis - globo series (8)
- Limonene and pinene degradation (8)
- One carbon pool by folate (8)
- Thiamine metabolism (8)
- Glycosphingolipid biosynthesis - lacto and neolacto series (7)
- Ubiquinone and other terpenoid-quinone biosynthesis (7)
- Caffeine metabolism (6)
- Glycosphingolipid biosynthesis - ganglio series (6)
- Sulfur metabolism (6)
- Fatty acid elongation in mitochondria (5)
- Heparan sulfate biosynthesis (5)
- Protein export (5)
- Taurine and hypotaurine metabolism (5)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (4)
- Methane metabolism (4)
- Phenylalanine (4)
- tyrosine and tryptophan biosynthesis (4)
- RNA polymerase (3)
- Chondroitin sulfate biosynthesis (2)
- Fatty acid biosynthesis (2)
- O-Glycan biosynthesis (2)
- Vitamin B6 metabolism (2)
- Biotin metabolism (1)
- D-Arginine and D-ornithine metabolism (1)
- D-Glutamine and D-glutamate metabolism (1)
- Keratan sulfate biosynthesis (1)
- Lysine biosynthesis (1)